William Ho

William Ho

Company: IN8Bio

Job title: CEO


Sharing Results of Allogeneic Gamma Delta Therapy in AML Patients 4:00 pm

Discussing the rationale for developing chemo-resistant gamma delta therapy and clinical trial design as an adjuvant with current standard-of-care Choosing indications based on medical need and biological features of gamma delta T cells Presenting clinical results from phase 1 studies, highlighting efficacy and toxicity dataRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.